Milliman has released the results of its latest Individual Disability Income (IDI) Market Survey. The report, in its tenth edition, measures sales trends across 14 IDI companies, representing 90% of the market. The survey also covers recent changes in underwriting and products, the range of views that companies have on the current profitability of their business, and the favorable and unfavorable trends that can affect the long-term profitability of the IDI market. New this year, the report also includes a section discussing companies’ progress implementing the new 2013 Valuation Table.
Key findings include:
• Combined IDI new premium from the 14 IDI companies increased in 2016 by 1.3%, compared to 5.7% in 2015. Combined IDI new premium year-to-date through June 30, 2017 increased by 9.0% over the prior year.
• New premium from the employer-sponsored multi-life market exceeded 43% of total IDI new premium in 2015 and 2016.
• There is continued stability in the share of new IDI premium from doctors.
• The share of new IDI premium issued using voluntary guaranteed standard issue (GSI) underwriting was 32-34% in 2015 and 2016.
The decision of a major player to exit the individually-sold IDI market this past year appears to be benefitting other IDI companies in 2017, as they take on a portion of those sales. We believe this is a short-term impact. In the longer term, overall IDI market growth may be constrained by the loss of one of the larger writers of IDI business.
To download the full IDI Market Survey, click here.
The prevalence of multiple sclerosis (MS) in Japan is relatively low compared with that in the United States and Europe. However, the number of MS patients in Japan has been steadily increasing in recent years. This article coauthored by Milliman’s Kosuke Iwasaki and Yusuke Nakamura analyzes health insurance claims data to determine the current treatment status and medical cost of MS in Japan.
This article was originally published in Clinical and Neuroimmunology.
The 2016 U.S. Group Disability Market Survey covers employer-paid and employee-paid short-term disability and long-term disability insurance products and includes an analysis of premiums, cases, and covered lives from new sales and in-force business in 2015 and 2016. Twenty disability insurance companies contributed to the 2016 survey. Milliman consultants Paul Correia and Jennifer Fleck offer some perspective.
Milliman today released the results of its latest Individual Disability Income (IDI) Market Survey report. The report, in its ninth edition, measures sales trends across 15 IDI companies, representing 90% to 95% of the market. The survey also covers recent changes in underwriting and products, the range of views that companies have on the current profitability of their business, and the favorable and unfavorable trends that can affect the long-term profitability of the IDI market.
The 2016 survey results identify some very favorable trends, including:
• A combined new annualized premium of $392.2 million, highest since the 1990s
• A solid 5.8% growth in new annual premium from 2014 to 2015
• New premium from the employer-sponsored multi-life market exceeding 40% of total IDI new premium in 2014 and 2015
• A stabilization in the share of new IDI premium from doctors
• A reduction in the share of new IDI premium issued using voluntary guaranteed standard issue (GSI) underwriting
It’s been a tumultuous 10 years for individual disability income carriers. What Milliman’s IDI Market Survey reveals is that 2016 presents a much healthier picture of the market than in many years past. The survey sheds light on the causes and trends behind this optimistic outlook, and is a valuable resource for any companies looking to mitigate risk in a competitive environment.
To read the entire IDI Market Survey report, click here.
For more information email me.
Milliman consultants Al Schmitz, Daniel Nitz, Tim Kempen have published a long-term care (LTC) insurance valuation survey. The survey reviews and documents the assumptions and methodologies related to the determination and testing of active life and disabled life reserves as well as the asset strategies and investments backing the reserves.
To download the research report, click here.
Milliman today announced the second iteration of its research into the administrative expenses associated with Medicaid managed care plans. This research complements the analysis of Medicaid managed care financial results report that was released on June 6, 2016. The information has considerable value, given the Centers for Medicare and Medicaid Services (CMS) Medicaid managed care rule (CMS-2390-F), published on April 25, 2016, and historical CMS Medicaid capitation rate-setting guidance. These regulations require greater documentation of administrative costs included in the capitation rates and this information can be useful in providing greater transparency of the rate-setting process.
The additional analysis on administrative expenses is critical in helping understand the true expenses incurred by Medicaid managed care organizations. The recent approval of the Medicaid managed care rule highlights the focus placed on each component of the managed care capitation rates. We believe that this research can become as familiar in the industry as our financial analysis report to help establish benchmarks for use in rate setting.
Key findings from the analysis include:
• The average administrative loss ratio (ALR) for Medicaid-focused plans is 8.8% after removing the impact of taxes and fees
• Calendar year (CY) 2014 and 2015 ALR values, net of taxes and fees, are considerably lower than in previous years
• The administrative per member per month (PMPM) value continues to climb as average premium levels increase
This is the second year the administrative expenses report has been produced, with expectation of providing future annual updates consistent with the Medicaid managed care organization financial results report.
To see the Medicaid administrative expenses report, click here.